Related Experiment Video
Updated: Feb 13, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Stem cell control and cancer initiation by an autocrine, injury-activated Igf complex
Yue Zhang1,2, Youcef Ouadah1,3, Yin Liu1
1Stanford University Department of Biochemistry, Stanford, CA 94305, USA.
Abstract:
Stem cells rapidly proliferate after injury to repair damaged tissue, and chronic injury predisposes to cancer. However, injury-activated mitogens, the mechanisms that keep them inactive until injury, and their role in cancer are not understood. Here we identify Igf2 as the injury-activated mitogen for neuroendocrine stem cells, a facultative airway stem cell and origin of small cell lung cancer. Igf2 is constitutively produced by the stem cells but sequestered in inactive form by co-expressed Igf binding proteins. Injury releases Igf2 and induces proliferation by activating its receptors and repressing Rb tumor suppressor, which normally enforces stem cell quiescence. Persistent pathway activation initiates oncogenesis. Thus, in addition to its classical hormonal roles in physiology, growth, and aging, Igf operates locally with Igf binding proteins and Rb to control injury-induced stem cell activation and cancer. This pathway may also control related stem cells and cancers of the body and brain.
Insights
Injury activates Insulin-like Growth Factor 2 (IGF2) in airway stem cells, driving proliferation and initiating small cell lung cancer. This pathway involves IGF binding proteins and Rb, controlling stem cell activation and oncogenesis.
Area of Science:
- Cell Biology
- Cancer Research
- Pulmonology
Background:
- Stem cell proliferation after injury aids tissue repair but chronic injury can lead to cancer.
- Mechanisms of injury-activated mitogens and their role in cancer initiation are not fully understood.
Purpose of the Study:
- To identify the injury-activated mitogen for neuroendocrine stem cells.
- To elucidate the role of this mitogen in small cell lung cancer (SCLC) development.
Main Methods:
- Identification of Insulin-like Growth Factor 2 (IGF2) as the key mitogen.
- Analysis of IGF2 sequestration by IGF binding proteins.
- Investigation of the role of Rb tumor suppressor in regulating stem cell quiescence.
Main Results:
- IGF2 is identified as the injury-activated mitogen for airway neuroendocrine stem cells.
- Injury releases sequestered IGF2, activating proliferation via receptor signaling and Rb repression.
- Persistent activation of this pathway leads to oncogenesis and SCLC initiation.
Conclusions:
- IGF2, acting locally with IGF binding proteins and Rb, controls injury-induced stem cell activation and cancer.
- This pathway is crucial for understanding and potentially targeting SCLC.
- The findings suggest potential roles in other stem cell-related cancers.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adult Stem Cells

